Hsu Chung Gabriel Chen

Title: Hsu Chung Gabriel Chen: Innovator in Veterinary Biotechnology

Introduction

Hsu Chung Gabriel Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of veterinary biotechnology, particularly in the development of immunogenic compositions and test kits for porcine circovirus type 2 (PCV2). With a total of 4 patents to his name, Chen's work has had a substantial impact on animal health.

Latest Patents

Among his latest patents, Chen has developed a novel porcine circovirus type 2 (PCV2) strain, which is crucial for creating effective immunogenic compositions. His invention includes PCV2 test kits and applications of the novel strain, enhancing the ability to diagnose and manage infections in pigs. Additionally, he has worked on a vaccine derived from the novel E-ict-VL33 strain, which is designed to protect fish, particularly catfish, from infections. This method involves a primary immersion immunization followed by an oral vaccination, resulting in strong and long-lasting immunity for the fish.

Career Highlights

Throughout his career, Hsu Chung Gabriel Chen has been associated with notable companies such as Schweitzer Biotech Company Ltd. and Sbc Virbac Limited. His work in these organizations has allowed him to advance his research and contribute to innovative solutions in veterinary medicine.

Collaborations

Chen has collaborated with esteemed colleagues, including Tsun-Yung Kuo and Chung-Chin Wu, to further enhance his research and development efforts. These collaborations have played a vital role in the success of his projects and the advancement of veterinary biotechnology.

Conclusion

Hsu Chung Gabriel Chen is a distinguished inventor whose work in veterinary biotechnology has led to significant advancements in animal health. His innovative patents and collaborations reflect his commitment to improving the welfare of animals through scientific research.